Recombinant Human ZBTB12 Protein，GST

ZBTB12, also known as ZNF599, is a member of the zinc finger and BTB (Bric-a-brac, Tramtrack, and Bric-a-brac) domain-containing protein family, which plays crucial roles in various biological processes, including transcriptional regulation, cell differentiation, and immune responses. Research on ZBTB12 has gained traction due to its implications in cancer biology, where it has been identified as a potential tumor suppressor gene and a key player in the regulation of cell proliferation and apoptosis. The protein's ability to modulate gene expression via its interaction with chromatin and other transcriptional factors makes it an attractive target for therapeutic investigations. Moreover, its involvement in inflammatory responses and immune regulation suggests a broader role in cellular homeostasis and disease pathology. Understanding ZBTB12's functions through the development of recombinant protein models enables researchers to elucidate its mechanistic pathways and interactions with other cellular components. The recombinant ZBTB12 protein could facilitate studies aimed at exploring its structural characteristics, post-translational modifications, and potential as a biomarker or therapeutic target in various diseases, particularly in oncology and immunology. Recent advancements in recombinant DNA technology and protein expression systems have paved the way for harnessing ZBTB12 for further studies, aiming to unlock its potential in clinical applications and provide insights into the molecular underpinnings of diseases associated with its dysregulation. This research is crucial for developing targeted therapies that could improve patient outcomes in cancer and other disorders related to the immune system.